CREIGHTON UNIVERSITY TO DEMONSTRATE ENDOLUMINAL GASTROPLICATION FOR ENDOSCOPIC TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD)
LIVE INTERNET BROADCAST
Monday, March 3 at 11AM EST
February 18, 2003 --
Omaha, NE. – Dr. Charles Filipi at Creighton University Medical Center with Dr. Isaac Raijman of Texas Medical Center will endoscopically treat a patient with Gastroesophageal Reflux Disease using The Bard® EndoCinch™ device. The live webcast of the procedure will take place on Monday, March 3 at 11AM EST. Health care professionals and patients will have the ability to observe a live procedure as well as e-mail questions directly to the presenting physicians during the webcast.
What is Endoluminal Gastroplication?
Endoluminal Gastroplication is a medical therapy developed for the treatment of symptomatic Gastroesophageal Reflux Disease (GERD). The procedure works by creating plications, or pleats, at the lower esophageal sphincter (LES). Performing the procedure has been shown to significantly improve symptoms and regurgitation while reducing or eliminating patients' dependence on acid-controlling medications.
How is the procedure performed?
The EndoCinch System, like a tiny sewing machine, is attached to the end of a standard, flexible endoscope or tube, which allows the physician to place suture (stitch) near the LES. Two stitches can be placed and tied together to create a pleat near the LES and treat symptomatic reflux or acid reflux.
Where is the procedure performed?
The procedure is typically performed in the hospital or surgical center, on an outpatient basis, so that patients can return home the same day. Typically, only mild sedation is required (no general anesthesia) and patients can return to normal activities the next day.
The Internet broadcast will use RealPlayer to display both video and synchronized slides in side-by-side windows. Viewers can download a free copy of the player from one of the links on this page. It is not necessary to purchase any of Real's premium players or subscription plans. The free basic player is all that is required to view the surgery.
About C. R. Bard, Inc.
C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer and marketer of healthcare products. Bard Endoscopic Technologies, headquartered in Billerica, MA, is a division of C. R. Bard, Inc. (NYSE-BCR), specializing in the field of gastroenterology. For more than ten years, Bard Endoscopic Technologies (formerly Bard Interventional Products) has been developing minimally invasive diagnostic and therapeutic products used in conjunction with procedures requiring flexible endoscopy. Visit the company website at www.crbard.com.
Find a Physician
